Organization
Melanoma and Skin Cancer Trials Limited
6 clinical trials
1 abstract
Clinical trial
A Randomised Double-blind Placebo-controlled Trial of Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant RecipientsStatus: Not yet recruiting, Estimated PCD: 2026-05-15
Clinical trial
Bevacizumab and Immune chEckpoint Inhibitors Plus Hypofractionated Stereotactic radioTherapy for the Treatment of sympTomatic mElanoma bRain Metastases.Status: Not yet recruiting, Estimated PCD: 2026-01-30
Clinical trial
A Phase Ib/II Study of Combination Avelumab With Peptide Receptor Radionuclide Therapy or Conventional Fractionated Radiotherapy in Patients With Metastatic Merkel Cell CarcinomaStatus: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Randomised, Placebo-controlled, Phase II Trial of Adjuvant Avelumab in Patients With Stage I-III Merkel Cell CarcinomaStatus: Recruiting, Estimated PCD: 2027-04-01
Clinical trial
Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell CarcinomaStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Abstract
CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.Org: Peter MacCallum Cancer Centre, Melbourne, Australia, Sir Charles Gairdner Hospital, Harry Perkins Institute for Medical Research, University of Western Australia & Linear Clinical Research, Melbourne, Australia,
Clinical trial
A Randomised Controlled Multicentre Trial of Imiquimod Versus Radiotherapy for Lentigo Maligna (LM) When Staged Surgical Excision With 5mm Margins is Not Possible, is Refused, or FailsStatus: Completed, Estimated PCD: 2021-12-24